MRK Relative Valuation
MRK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MRK is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for MRK's competitors is 4.39, providing a benchmark for relative valuation. Merck & Co Inc Corp (MRK) exhibits a P/S ratio of 2.91, which is -33.70% above the industry average. Given its robust revenue growth of -1.56%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Merck & Co Inc (MRK) currently overvalued or undervalued?
What is Merck & Co Inc (MRK) fair value?
How does MRK's valuation metrics compare to the industry average?
What is the current P/B ratio for Merck & Co Inc (MRK) as of May 19 2025?
What is the current FCF Yield for Merck & Co Inc (MRK) as of May 19 2025?
What is the current Forward P/E ratio for Merck & Co Inc (MRK) as of May 19 2025?